Quotient acquires GE Healthcare's radiolabelling unit
This article was originally published in Scrip
Executive Summary
Quotient Bioresearch is to acquire Amersham Radiolabelling Services, the radiochemical custom synthesis operations of GE Healthcare, in the latest in a line of acquisitions since its formation in early 2007 (scripnews.com, May 19th, 2009).